Rosanne Longmore and Helen Barry are the co-founders of Coroflo, an innovative medical device company trans-forming infant care that officially launched on the market this year. Coroflo has developed the world’s first breast-feeding monitor that accurately measures breast milk intake. Driven by a shared mission to empower parents and enhance infant health, Longmore and Barry have created a pioneering product that addresses one of the most common challenges in early childcare – ensuring newborns receive adequate nutrition. Longmore was met with a lack of interest from investors which galvanised her to bootstrap the company to success and secure Co- roflo’s validation on its own. It uses a standard silicone nipple shield with an embedded patented micro-flow metre, alongside an app that helps mothers monitor the milk flow to their baby. With concerns over low supply often cited as a reason to stop breastfeeding, the monitor strives to dispel the lack of real-time information. Longmore, the CEO of Coroflo, has a background in healthcare and technology and has driven the business from concept to reality, securing necessary funding and building partnerships with medical experts and investors. Barry, as COO, oversees the operations and product development that bring Coroflo’s vision to life. With her background in engineering and operational management, she has been instrumental in managing the technical and regulatory aspects of Coroflo. This MedTech device, which has already secured FDA approval, is a significant breakthrough for femtech and will provide breastfeeding data to medical researchers which has never been available before.
